SOX6 expression and aneurysms of the thoracic and abdominal aorta.
Cardiovascular medicine
Medical science
Molecular Genetics
Journal
iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038
Informations de publication
Date de publication:
20 Sep 2024
20 Sep 2024
Historique:
received:
29
08
2022
revised:
31
01
2024
accepted:
28
06
2024
medline:
12
9
2024
pubmed:
12
9
2024
entrez:
12
9
2024
Statut:
epublish
Résumé
Abdominal and thoracic aortic aneurysms (AAAs, TAAs) remain a major cause of deaths worldwide, in part due to the lack of reliable prognostic markers or early warning signs. Sox6 has been found to regulate renin controlling blood pressure. We hypothesized that Sox6 may serve as an important regulator of the mechanisms contributing to hypertension-induced aortic aneurysms. Phenotype and laboratory-wide association scans in a clinical cohort found that SOX6 gene expression is associated with aortic aneurysm in subjects of European ancestry. Sox6 and tumor necrosis factor alpha (TNF-α) expression were upregulated in aortic tissues from patients affected by either AAA or TAA. In Sox6 knockout mice with angiotensin-II-induced AAA, we found that Sox6 plays critical role in the development and progression of AAA. Our data support a regulatory role of SOX6 in the development of hypertension-induced AAA, suggesting that Sox6 may be a therapeutic target for the treatment of aortic aneurysms.
Identifiants
pubmed: 39262802
doi: 10.1016/j.isci.2024.110436
pii: S2589-0042(24)01661-4
pmc: PMC11388018
doi:
Types de publication
Journal Article
Langues
eng
Pagination
110436Informations de copyright
© 2024 Published by Elsevier Inc.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest, financial, or otherwise.